ALK and lymphoma: Indeed, in ALK-positive lymphoma sensitive cell lines (K299, SUP-M2), previous 20 h exposure to crizotinib or lorlatinib (i.e., 0.5 μM and 0.1 μM, respectively) induced increased phagocytosis with anti-CD47 mAb (Figure 3A).